125 related articles for article (PubMed ID: 38267103)
1. Improving COVID-19 vaccine response in individuals receiving methotrexate.
Bechman K; Galloway J
Lancet Rheumatol; 2024 Feb; 6(2):e67-e68. PubMed ID: 38267103
[No Abstract] [Full Text] [Related]
2. Improving COVID-19 vaccine immunogenicity by interrupting methotrexate treatment.
Sparks JA; Tedeschi SK
Lancet Respir Med; 2022 Sep; 10(9):813-815. PubMed ID: 35772415
[No Abstract] [Full Text] [Related]
3. Impact of methotrexate treatment on vaccines immunogenicity in adult rheumatological patients - Lessons learned from the COVID-19 pandemic.
Wroński J; Ciechomska M; Kuca-Warnawin E
Biomed Pharmacother; 2023 Sep; 165():115254. PubMed ID: 37542854
[TBL] [Abstract][Full Text] [Related]
4. Vaccine hesitancy over the upcoming COVID-19 vaccine - A thought-provoking concern with regards to the present scenario.
Mishra A; Boratne AV; Bahurupi Y
Indian J Med Microbiol; 2021 Jul; 39(3):392. PubMed ID: 34053810
[No Abstract] [Full Text] [Related]
5. The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study.
Al-Janabi A; Ra A; Littlewood Z; Foulkes AC; Hunter HJA; Chinoy H; Moriarty CA; Hyrich KL; Limdi JK; Yiu ZZN; Griffiths CEM; Warren RB
Br J Dermatol; 2023 Mar; 188(4):542-551. PubMed ID: 36695406
[TBL] [Abstract][Full Text] [Related]
6. The online anti-vaccine movement in the age of COVID-19.
Burki T
Lancet Digit Health; 2020 Oct; 2(10):e504-e505. PubMed ID: 32984795
[No Abstract] [Full Text] [Related]
7. In brief: Pfizer/BioNTech COVID-19 vaccine authorized for children 5-11 years old.
Med Lett Drugs Ther; 2021 Nov; 63(1638):185. PubMed ID: 35085214
[No Abstract] [Full Text] [Related]
8. COVID-19 Vaccine Hesitancy.
Price S
Tex Med; 2021 Jan; 117(1):42-44. PubMed ID: 33641116
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 vaccine on board ships: current and future implications of seafarers.
Battineni G; Kumar S; Mittal M; Amenta F
Int Marit Health; 2021; 72(1):76-77. PubMed ID: 33829476
[No Abstract] [Full Text] [Related]
10. Migraine treatment and COVID-19 vaccines: No cause for concern.
Gelfand AA; Poland G
Headache; 2021 Mar; 61(3):409-411. PubMed ID: 33543775
[No Abstract] [Full Text] [Related]
11. Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review.
Parker EPK; Desai S; Marti M; Nohynek H; Kaslow DC; Kochhar S; O'Brien KL; Hombach J; Wilder-Smith A
Lancet Glob Health; 2022 Mar; 10(3):e326-e328. PubMed ID: 35180408
[No Abstract] [Full Text] [Related]
12. Effect of interrupting methotrexate treatment on COVID-19 booster vaccine response.
Drug Ther Bull; 2022 Nov; 60(11):163. PubMed ID: 36261277
[No Abstract] [Full Text] [Related]
13. COVID symptoms, testing, shielding impact on patient-reported outcomes and early vaccine responses in individuals with multiple myeloma.
Ramasamy K; Sadler R; Jeans S; Varghese S; Turner A; Larham J; Gray N; Barrett J; Bowcock S; Cook G; Kyriakou C; Smith D; Drayson M; Basu S; Moore S; McDonald S; Gooding S; Javaid MK
Br J Haematol; 2022 Jan; 196(1):95-98. PubMed ID: 34341984
[No Abstract] [Full Text] [Related]
14. COVID-19 in Children: Clinical Manifestations and Pharmacologic Interventions Including Vaccine Trials.
Galindo R; Chow H; Rongkavilit C
Pediatr Clin North Am; 2021 Oct; 68(5):961-976. PubMed ID: 34538306
[TBL] [Abstract][Full Text] [Related]
15. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
[No Abstract] [Full Text] [Related]
16. COVID-19 vaccines for patients with haematological conditions.
Sun C; Pleyer C; Wiestner A
Lancet Haematol; 2021 May; 8(5):e312-e314. PubMed ID: 33811822
[No Abstract] [Full Text] [Related]
17. Medicolegal consequences of altered COVID-19 vaccine administration.
Muir G; Crowther J
J R Soc Med; 2021 May; 114(5):244-245. PubMed ID: 33821691
[No Abstract] [Full Text] [Related]
18. What it will take to equitably distribute a COVID-19 vaccine.
Medina-Walpole A
Geriatr Nurs; 2020; 41(6):1028-1029. PubMed ID: 33187757
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.
Bugatti S; De Stefano L; Balduzzi S; Greco MI; Luvaro T; Cassaniti I; Bogliolo L; Mazzucchelli I; D'Onofrio B; di Lernia M; Mauric E; Lilleri D; Baldanti F; Manzo A; Montecucco C
Ann Rheum Dis; 2021 Dec; 80(12):1635-1638. PubMed ID: 34172502
[No Abstract] [Full Text] [Related]
20. Arrival of Covid-19 vaccine cheers Alaska hospital's staff.
Traynor K
Am J Health Syst Pharm; 2021 Feb; 78(5):367-368. PubMed ID: 33605990
[No Abstract] [Full Text] [Related]
[Next] [New Search]
